Jennifer Wargo

Associate Professor, Surgical Oncology
The University of Texas MD Anderson Cancer Center

Dr. Wargo’s career commitment is to advance the understanding and treatment of disease through science.  After completing her medical degree, she entered surgical residency training at the Massachusetts General Hospital/Harvard Medical School where she became interested in the biology and treatment of cancer.  During her training, she completed two fellowships in surgical oncology with a focus on immunotherapy for cancer.  Dr. Wargo was recruited to the Division of Surgical Oncology at Massachusetts General Hospital in July 2008 and had an active research laboratory focusing on melanoma tumorigenesis and immunotherapy for cancer.

Dr. Wargo has contributed significantly to the world literature regarding resistance mechanisms and the effect of targeted therapy on anti-tumor immunity. Dr. Wargo was recruited to University of Texas MD Anderson Cancer Center in September 2013 to continue this work and to build a program to collect serial biopsies in patients with melanoma and other cancers on targeted therapy and immunotherapy, and to better understand responses to therapy and to develop novel strategies to combat resistance.